Article Details
Retrieved on: 2021-06-15 18:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
What is going on with CERE? Cerevel Therapeutics (CERE) stock declined today after the neuroscience company announced that the FDA has granted ...
Article found on: www.investorsobserver.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here